| Whole sample (N = 302) | Before COVID-19 lockdown (n = 116) | During COVID-19 lockdown (n = 186) | Differences | ||||||||
M (SD) or % | Mdn | S-W | M (SD) or % | Mdn | S-W | M (SD) or % | Mdn | S-W | z, t, or χ2 | p | d or V | |
Age | 34.5 (14.5) | 25 | <0.001 | 29.6 (12.7) | 23 | <0.001 | 37.6 (14.8) | 44 | <0.001 | 4.94 | <0.001 | 0.57 |
Gender (% women) | 64.1% |
|
| 61.7% |
|
| 65.9% |
|
| 0.54 | n.s. | 0.04 |
Education (% high school) | 61.3% |
|
| 56.0% |
|
| 64.5% |
|
| 2.16 | n.s. | 0.08 |
Migration background | 12.1% |
|
| 15.8% |
|
| 9.8% |
|
| 2.39 | n.s. | 0.09 |
Parenthood | 45.5% |
|
| 36.2% |
|
| 51.3% |
|
| 6.59 | 0.010 | 0.15 |
Currently living in couple | 65.8% |
|
| 62.9% |
|
| 67.6% |
|
| 0.68 | n.s. | 0.05 |
Illness requiring treatment | 34.8% |
|
| 34.9% |
|
| 34.8% |
|
| <0.001 | n.s. | 0.001 |
Past hospitalization | 86.1% |
|
| 85.2% |
|
| 86.6% |
|
| 0.11 | n.s. | 0.02 |
Past psychiatric hospitalization | 7.0% |
|
| 9.5% |
|
| 5.4% |
|
| 1.82 | n.s. | 0.08 |
Past psychiatric treatment | 20.2% |
|
| 20.7% |
|
| 19.9% |
|
| 0.03 | n.s. | 0.01 |
Current psychopharmacology | 4.0% |
|
| 6.0% |
|
| 2.7% |
|
| 2.04 | n.s. | 0.08 |
BFI-neuroticism* | 2.86 (0.65) | 3.0 | n.s. | 2.83 (0.66) | 3.0 | n.s. | 2.89 (0.65) | 3.0 | n.s. | 0.75 | n.s. | 0.09 |
BFI-extraversion* | 3.20 (0.72) | 3.0 | n.s. | 3.21 (0.76) | 3.0 | n.s. | 3.19 (0.70) | 3.0 | n.s. | 0.15 | n.s. | 0.02 |
BFI-openness* | 3.16 (0.74) | 3.5 | 0.001 | 3.11 (0.73) | 3.2 | n.s. | 3.20 (0.75) | 3.2 | 0.004 | 1.03 | n.s. | 0.12 |
BFI-agreeableness* | 3.43 (0.74) | 3.2 | n.s. | 3.40 (0.74) | 3.5 | n.s. | 3.44 (0.62) | 3.5 | n.s. | 0.48 | n.s. | 0.06 |
BFI-consciousness* | 3.07 (0.65) | 3.0 | n.s. | 2.95 (0.64) | 2.9 | n.s. | 3.14 (0.65) | 3.1 | n.s. | 2.39 | 0.017 | 0.28 |
Internal attribution style** | 7.94 (1.44) | 8.0 | <0.001 | 8.10 (1.24) | 8.0 | <0. 001 | 7.84 (1.55) | 8.0 | <0.001 | 1.02 | n.s. | 0.18 |
External attribution style** | 4.72 (1.46) | 5.0 | 0.001 | 4.89 (1.49) | 5.0 | 0.038 | 4.62 (1.44) | 5.0 | 0.001 | 1.16 | n.s. | 0.18 |
Self-efficacy* | 17.6 (2.6) | 18.0 | n.s. | 17.4 (2.6) | 18.0 | n.s. | 17.8 (2.6) | 18.0 | n.s. | 1.28 | n.s. | 0.15 |